Catalent Inc (CTLT)
59.68
+0.68
(+1.15%)
USD |
NYSE |
Nov 21, 14:58
Catalent Price: 59.68 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 58.68 | 59.04 | 58.68 | 59.00 | 1.407M |
| Nov 19, 2024 | 58.51 | 58.98 | 58.39 | 58.88 | 1.098M |
| Nov 18, 2024 | 59.10 | 59.13 | 58.58 | 58.78 | 1.724M |
| Nov 15, 2024 | 58.99 | 59.35 | 58.73 | 59.10 | 1.488M |
| Nov 14, 2024 | 59.15 | 59.38 | 58.91 | 58.91 | 1.123M |
| Nov 13, 2024 | 59.21 | 59.52 | 59.08 | 59.15 | 1.415M |
| Nov 12, 2024 | 59.53 | 59.76 | 59.14 | 59.25 | 1.364M |
| Nov 11, 2024 | 59.77 | 59.96 | 59.35 | 59.46 | 1.019M |
| Nov 08, 2024 | 59.81 | 59.98 | 59.34 | 59.41 | 2.565M |
| Nov 07, 2024 | 60.01 | 60.21 | 59.85 | 59.92 | 2.188M |
| Nov 06, 2024 | 59.60 | 60.06 | 59.48 | 59.95 | 4.196M |
| Nov 05, 2024 | 58.50 | 58.92 | 58.30 | 58.48 | 1.714M |
| Nov 04, 2024 | 58.92 | 59.21 | 58.52 | 58.69 | 1.996M |
| Nov 01, 2024 | 58.51 | 58.83 | 58.50 | 58.73 | 1.704M |
| Oct 31, 2024 | 58.95 | 58.95 | 58.57 | 58.60 | 1.174M |
| Oct 30, 2024 | 58.62 | 59.25 | 58.52 | 58.97 | 1.686M |
| Oct 29, 2024 | 58.88 | 58.90 | 58.62 | 58.66 | 1.926M |
| Oct 28, 2024 | 59.29 | 59.32 | 58.74 | 58.81 | 1.393M |
| Oct 25, 2024 | 59.50 | 59.50 | 59.00 | 59.09 | 2.467M |
| Oct 24, 2024 | 59.50 | 59.73 | 59.25 | 59.50 | 2.908M |
| Oct 23, 2024 | 59.50 | 59.64 | 59.35 | 59.40 | 2.429M |
| Oct 22, 2024 | 60.14 | 60.32 | 59.56 | 59.92 | 2.568M |
| Oct 21, 2024 | 60.34 | 60.40 | 60.14 | 60.18 | 772649.0 |
| Oct 18, 2024 | 60.00 | 60.39 | 59.95 | 60.29 | 908424.0 |
| Oct 17, 2024 | 60.30 | 60.34 | 59.94 | 60.09 | 2.017M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
31.86
Minimum
May 16 2023
142.35
Maximum
Sep 08 2021
77.82
Average
70.35
Median
Feb 14 2023
Price Benchmarks
| Eli Lilly and Co | 750.94 |
| Boston Scientific Corp | 91.53 |
| Pfizer Inc | 24.93 |
| Merck & Co Inc | 99.49 |
| BioCardia Inc | 2.08 |
Price Related Metrics
| PS Ratio | 2.453 |
| Price to Book Value | 3.058 |
| Price to Free Cash Flow | 109.56 |
| Earnings Yield | -3.80% |
| Market Cap | 10.83B |